FDA Warns Irisys Over Production Process Issues
The U.S. Food and Drug Administration has issued a formal warning to Irisys Inc. over alleged problems with its drug production process, saying the company does not have procedures in place...To view the full article, register now.
Already a subscriber? Click here to view full article